HK StockDetailed Quotes

Provided by TTMF Limited

MICOT PHARMA-BUnlisted

18.200

0.000

Volume:- -

Turnover:- -

Market Cap:6.04B

PE:- -

High:- -

Open:- -

Low:- -

Close:18.200

52wk High:- -

52wk Low:- -

Shares:331.74M

HK Float Shares:274.00M

Volume Ratio:- -

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:-33.11%

PB:-5.38

PE(LYR):- -

PS:17847.04

1

Offering

Jun 15

2

Closed

Jun 18 10:15

3

IPO Result

Jun 22

4

Grey Mkt.

Jun 23 16:15 - 18:30

5

Listing

Jun 24

Overview Company News Filings

MICOT PHARMA-B IPO Concludes with Strong Oversubscription, Raising HK$789 Billion in Margin Financing

Hong Kong Stocks Start Week Marginally Higher; Two Firms File to Go Public in Hong Kong

MT Newswires Live

Shaanxi Micot Pharmaceutical Technology Seeks HK$1.2 Billion in Hong Kong IPO

MT Newswires Live

陕西麦可特医药启动香港首发，发行价介乎每股18.20港元至21.00港元，拟于2026年6月24日挂牌交易

Bulletin Express

BRIEF-Shaanxi Micot Pharmaceutical Technology Says Maximum Offer Price Under Global Offering HK$21.0 Per H Share

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/02335/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02335","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02335\",,,,,undefined,":{"symbol":"02335","market":"HK","secType":"STK","nameCN":"MICOT PHARMA-B","latestPrice":18.2,"timestamp":1781769600000,"preClose":18.2,"halted":9,"volume":0,"delay":0,"changeRate":0,"floatShares":274000000,"shares":331740350,"eps":0,"marketStatus":"To be listed","change":0,"latestTime":"06-18 16:00:00","open":0,"high":0,"low":0,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.637,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1782264600000},"marketStatusCode":8,"adr":0,"listingDate":1782230400000,"exchange":"SEHK","adjPreClose":18.2,"openAndCloseTimeList":[[1781746200000,1781755200000],[1781758800000,1781769600000]],"volumeRatio":0,"ipoDetail":{"name":"麦科医药－Ｂ","exchange":"SEHK","listingDate":"2026-06-24","sharesOutstanding":331740350,"sharesFloat":331740350,"offerAmount":58054400,"priceRange":"18.200 - 21.000","market":"HK","openProspectusDate":"2026-06-15","openProspectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0615/2026061500010_c.pdf","purchaseBeginDate":"2026-06-15","purchaseEndDate":"2026-06-18","winningDate":"2026-06-23","currency":"HKD","minPurchaseQuantity":200,"peRate":-32.23,"use":"1、约39.1%或417.3百万港元，将用于核心产品的持续进行及计划的临床试验以及计划的商业推出；\n2、约36.3%或387.4百万港元，将用于关键产品的持续进行及计划的临床试验以及计划的商业推出；\n3、约14.6%或155.8百万港元，将用于其他候选产品及技术平台的研发；\n4、约10.0%或106.7百万港元，将用作营运资金及一般公司用途。","industryId":"204005","industryName":"医疗保健","business":"公司为一家平台型生物技术公司，致力于加速全球新一代双特异性/多特异性多肽药物的创新及开发，公司的核心产品处于III期临床试验；作为提出双/多特异性肽技术概念的全球先驱，并凭借进入临床开发的广泛候选产品管线，公司已在该领域确立领先地位。","subscribed":663.28,"marketCap":6038000000,"minimumCapital":4242.36,"overAllotment":true,"lotSize":200,"issueOpenRate":0.1,"subscribeGear":"200,400,600,800,1000,1200,1400,1600,1800,2000,3000,4000,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,200000,300000,400000,500000,600000,700000,800000,900000,1000000,2000000,2902800","issueRatio":0.1,"offeringMechanism":"B"},"greyMarketDetail":{"greyDate":"2026-06-23","greyDateTimestamp":1782144000000,"greyOpeningTime":1782202500000,"greyClosingTime":1782210600000,"showGreyQuote":false,"openProspectusDate":"2026-06-15","listingDate":"2026-06-24"},"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02335\",,,,,undefined,":{"symbol":"02335","floatShares":274000000,"roa":"-33.11%","roe":"--","lyrEps":0,"shares":331740350,"dividePrice":0,"high":0,"amplitude":0,"preClose":18.2,"low":0,"week52Low":0,"pbRate":"-5.38","psRate":"17847.04","week52High":0,"institutionHeld":0,"latestPrice":18.2,"eps":0,"divideRate":0,"volume":0,"delay":0,"ttmEps":-0.637,"open":0},"@#url:\"https://hktrade.skytigris.com/ipos/general/02335\",,undefined,":{"id":10148,"type":"COMMON","ipoName":"02335-IPO","symbol":"02335","companyName":"MICOT PHARMA-B","market":"HK","currency":"HKD","status":"CLOSED","underwriter":"CCB International Capital Limited","lotSize":200,"minQty":200,"expectedOfferingSize":58054400,"openingDate":1781487000000,"closingDate":1781748900000,"commonClosingDate":1781748900000,"allotmentDate":1782057600000,"listDate":1782230400000,"marginable":true,"latestPrice":21,"minPrice":18.2,"maxPrice":21,"prospectusUrl":"https://www1.hkexnews.hk/listedco/listconews/sehk/2026/0615/2026061500009.pdf","allowedQuantities":[200,400,600,800,1000,1200,1400,1600,1800,2000,3000,4000,5000,6000,7000,8000,9000,10000,20000,30000,40000,50000,60000,70000,80000,90000,100000,200000,300000,400000,500000,600000,700000,800000,900000,1000000,2000000,2902800],"recommend":false,"isHint":false,"interestStartDate":1781712000000,"interestEndDate":1781971200000,"delayAllocate":false,"isSupportGreyMarket":true,"greyMarketTradeDate":1782202500000,"transactionRate":0.010085,"gstFeeRate":0,"rank":0,"subscribed":false,"signed":false,"financingInfos":[],"financingNotifyEnabled":false,"financingNotifySubscribed":false,"subscriptionMethods":[],"latestClosingDate":1782015663013,"subscribedFinanceRatio":663.28,"subscribedRatio":663.28,"forecastRatio":862.26,"raiseMoney":121920000,"totalMargin":80865900000,"quoteInfoUpdatedAt":1782015660499,"prospectusUpdatedAt":1781486891000,"forecastMarketValue":6502110860,"minForecastMarketValue":6037674370,"maxForecastMarketValue":6966547350,"sharesOutstanding":331740350,"business":"公司为一家平台型生物技术公司，致力于加速全球新一代双特异性/多特异性多肽药物的创新及开发，公司的核心产品处于III期临床试验；作为提出双/多特异性肽技术概念的全球先驱，并凭借进入临床开发的广泛候选产品管线，公司已在该领域确立领先地位。","greyOpeningTime":1782202500000,"greyClosingTime":1782210600000,"tradable":false,"showClawback":true,"clawbackType":"Mechanism B","clawbackRate":10},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02335\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1130696049","title":"MICOT PHARMA-B IPO Concludes with Strong Oversubscription, Raising HK$789 Billion in Margin Financing","url":"https://stock-news.laohu8.com/highlight/detail?id=1130696049","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130696049?lang=en_us&edition=fundamental","pubTime":"2026-06-18 14:14","pubTimestamp":1781763284,"startTime":"0","endTime":"0","summary":"The public share offering for biotechnology firm MICOT PHARMA-B (02335) has concluded. The subscription period ran from June 15 to June 18, 2026.According to market information, the company has...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643276959","title":"Hong Kong Stocks Start Week Marginally Higher; Two Firms File to Go Public in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2643276959","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643276959?lang=en_us&edition=fundamental","pubTime":"2026-06-15 16:33","pubTimestamp":1781512419,"startTime":"0","endTime":"0","summary":"Hong Kong stocks began the week marginally higher as markets reacted to news of Iran and the U.S. reaching a preliminary deal to end hostilities and reopen the critical Strait of Hormuz.The Hang Seng ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["82828","MHImain","MCHmain","03419","HSTECH","09115","HHImain","07200","82800","07300","02800","06106","02833","07288","03037","03115","513600","83115","HSCEI","03416","02335","HSI","02828","07588","07500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643140226","title":"Shaanxi Micot Pharmaceutical Technology Seeks HK$1.2 Billion in Hong Kong IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2643140226","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643140226?lang=en_us&edition=fundamental","pubTime":"2026-06-15 10:03","pubTimestamp":1781488988,"startTime":"0","endTime":"0","summary":"Shaanxi Micot Pharmaceutical Technology  launched its Hong Kong initial public offering on Monday, seeking to raise up to HK$1.22 billion.The Chinese biotechnology company is offering 58.1 million H shares at an indicative maximum price of HK$21.00 per share, according to a Hong Kong bourse filing.The offering comprises 5.8 million shares for Hong Kong investors and 52.2 million shares for international investors, subject to reallocation and the over-allotment option.The offer price is expected to be determined by June 18, with allocation results due by June 23, ahead of the company's planned trading debut on June 24.Net proceeds, estimated at HK$1.07 billion, will be used primarily to fund the ongoing and planned clinical development and commercialization of Micot Pharmaceutical's core and key product candidates.The company also plans to use the funds for the research and development of other pipeline candidates and technology platforms, as well as for working capital and general corp","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["02335","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137177808","title":"陕西麦可特医药启动香港首发，发行价介乎每股18.20港元至21.00港元，拟于2026年6月24日挂牌交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1137177808","media":"Bulletin Express","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137177808?lang=en_us&edition=fundamental","pubTime":"2026-06-15 06:28","pubTimestamp":1781476118,"startTime":"0","endTime":"0","summary":"一、公司概况   陕西麦可特医药科技股份有限公司（下称「公司」）主要从事基于多肽的创新药物研发、开发与商业化业务，核心管线聚焦于代谢性、心血管及脑血管疾病领域，尚无已商业化产品。主要候选药物包括核心产品MT1013（适应症为慢性肾脏病-继发性甲状旁腺功能亢进等）、多重靶点肥胖管理及肝肾疾病治疗药物XTL6001、凝血因子II与GP...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"陕西麦可特医药启动香港首发，发行价介乎每股18.20港元至21.00港元，拟于2026年6月24日挂牌交易","news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643226450","title":"BRIEF-Shaanxi Micot Pharmaceutical Technology Says Maximum Offer Price Under Global Offering HK$21.0 Per H Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2643226450","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643226450?lang=en_us&edition=fundamental","pubTime":"2026-06-15 06:12","pubTimestamp":1781475171,"startTime":"0","endTime":"0","summary":"BRIEF-Shaanxi Micot Pharmaceutical Technology Says Maximum Offer Price Under Global Offering HK$21.0 Per H ShareJune 15  - Shaanxi Micot Pharmaceutical Technology: MAXIMUM OFFER PRICE UNDER GLOBAL OFFERING HK$21.0 PER H SHARENUMBER OF OFFER SHARES UNDER GLOBAL OFFERING 58.1 MILLION H SHARESNUMBER OF INTERNATIONAL OFFER SHARES UNDER GLOBAL OFFERING 52.2 MILLION H SHARES ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260614:nFWN42K0L5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02335"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}]}}